本页面由Tiger Trade Technology Pte. Ltd.提供服务

爵士制药

254.28
+5.582.24%
盘后254.280.00000.00%19:52 EDT
成交量:51.68万
成交额:1.31亿
市值:165.06亿
市盈率:17.38
高:255.85
开:248.75
低:248.55
收:248.70
52周最高:265.05
52周最低:121.40
股本:6,491.46万
流通股本:6,269.43万
量比:1.04
换手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):14.63
每股收益(LYR):-5.8403
净资产收益率:22.11%
总资产收益率:6.86%
市净率:3.44
市盈率(LYR):-43.54

数据加载中...

2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/24

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities